[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4260 followers
Created: 2025-07-08 12:45:06 UTC

$RXRX Asset Acquisitions:

On July 8, 2025, Recursion Pharmaceuticals acquired XX% of RE Ventures I, LLC from Rallybio for $XXX million in cash and shares (1,457,952 shares at $XXXXXX each), making RE Ventures an indirect wholly-owned subsidiary. The deal includes additional contingent payments based on future milestones.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942565607465181377/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[alternative investment](/topic/alternative-investment)
[sec](/topic/sec)
[$rxrx](/topic/$rxrx)

[Post Link](https://x.com/USCorpFilings/status/1942565607465181377)